9.06 USD
↗ 0.00 (0.00%)AT CLOSE (11:59 AM EDT)
Kyverna Therapeutics, Inc. Common Stock
KYTXNASDAQ • USD
9.25
↗ 0.19 (2.08%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
9.25
↗ 0.19 (2.08%)
Market: CLOSED
Open?$9.01
High?$9.59
Low?$8.61
Prev. Close?$9.06
Volume?1.5M
Avg. Volume?1.0M
VWAP?$9.12
Rel. Volume?1.43x
Bid / Ask
Bid?$7.91 × 100
Ask?$10.58 × 100
Spread?$2.67
Midpoint?$9.25
Valuation & Ratios
Market Cap?548.4M
Shares Out?60.5M
Float?16.9M
Float %?39.0%
P/E Ratio?N/A
P/B Ratio?2.36
EPS?-$2.66
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?7.75Strong
Quick Ratio?7.75Strong
Cash Ratio?3.40Strong
Debt/Equity?0.11Low
ValuationATTRACTIVELY VALUED
Score100/100
P/E?N/A▾
P/B?2.36CHEAP▾
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-2.7CHEAP▾
EV/Sales?N/A▾
Returns & Efficiency
ROE?-69.5%WEAK▾
ROA?-54.9%WEAK▾
Cash Flow & Enterprise
FCF?$-153717000
Enterprise Value?$449.4M
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product, KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.
Employees
130
Market Cap
548.4M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2024-02-08
Address
5980 HORTON STREET
EMERYVILLE, CA 94608
Phone: (510) 626-8331
EMERYVILLE, CA 94608
Phone: (510) 626-8331